Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
Clinical trial NCT05778071 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05778071
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-07
- Primary completion
- 2024-11-15
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.